These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20608938)

  • 1. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
    Bhattacharjee RN; Timoshenko AV; Cai J; Lala PK
    Cancer Sci; 2010 Sep; 101(9):2026-32. PubMed ID: 20608938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer.
    Timoshenko AV; Chakraborty C; Wagner GF; Lala PK
    Br J Cancer; 2006 Apr; 94(8):1154-63. PubMed ID: 16570043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma.
    Su JL; Shih JY; Yen ML; Jeng YM; Chang CC; Hsieh CY; Wei LH; Yang PC; Kuo ML
    Cancer Res; 2004 Jan; 64(2):554-64. PubMed ID: 14744769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
    Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
    Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.
    Wu QW; She HQ; Liang J; Huang YF; Yang QM; Yang QL; Zhang ZM
    BMC Cancer; 2012 Jan; 12():47. PubMed ID: 22284579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions of COX-2 and VEGF-C in gastric cancer: correlations with lymphangiogenesis and prognostic implications.
    Gou HF; Chen XC; Zhu J; Jiang M; Yang Y; Cao D; Hou M
    J Exp Clin Cancer Res; 2011 Jan; 30(1):14. PubMed ID: 21272377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of lymphangiogenesis and tumor lymphovascular invasion in indonesian breast cancers.
    Widodo I; Ferronika P; Harijadi A; Triningsih FE; Utoro T; Soeripto
    Asian Pac J Cancer Prev; 2013; 14(2):997-1001. PubMed ID: 23621275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral lymphangiogenesis induced by vascular endothelial growth factor C and D promotes lymph node metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Li Y; Dai M; Yuan ZX; Zhu YY; Luo CY
    World J Surg Oncol; 2012 Aug; 10():165. PubMed ID: 22906075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
    Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P
    Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.
    Sun P; Gao J; Liu YL; Wei LW; Wu LP; Liu ZY
    Mol Cell Biochem; 2008 Jan; 308(1-2):161-8. PubMed ID: 17938864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer.
    Liu H; Xiao J; Yang Y; Liu Y; Ma R; Li Y; Deng F; Zhang Y
    Microvasc Res; 2011 Sep; 82(2):131-40. PubMed ID: 21600223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
    Choi WW; Lewis MM; Lawson D; Yin-Goen Q; Birdsong GG; Cotsonis GA; Cohen C; Young AN
    Mod Pathol; 2005 Jan; 18(1):143-52. PubMed ID: 15297858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
    Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer.
    Lin Y; Liu F; Fan Y; Qian X; Lang R; Gu F; Gu J; Fu L
    Int J Clin Exp Pathol; 2015; 8(7):8028-37. PubMed ID: 26339369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients.
    Zhao YC; Ni XJ; Wang MH; Zha XM; Zhao Y; Wang S
    Med Oncol; 2012 Dec; 29(4):2594-600. PubMed ID: 22562155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.